Tochigi, Japan

Haruaki Kurasaki

This inventor holds 2 USPTO granted patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruaki Kurasaki. Retrieved from https://idiyas.com/inventor/haruaki-kurasaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Haruaki Kurasaki: Innovator in Pharmaceutical Research

Introduction

Haruaki Kurasaki is a notable inventor based in Shimotsuga, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic potential. His work is characterized by a focus on innovative solutions to complex medical challenges.

Latest Patents

Haruaki Kurasaki holds a patent for a 15-PGDH inhibitor. This invention is a compound represented by a general formula (1) or a pharmacologically acceptable salt thereof, specifically designed for inhibiting 15-PDGH. This patent highlights his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Kurasaki is associated with Kyorin Pharmaceutical Co., Ltd., where he has been instrumental in research and development efforts. His work at this esteemed company has allowed him to explore new avenues in drug development and contribute to the pharmaceutical industry.

Collaborations

Throughout his career, Haruaki Kurasaki has collaborated with talented individuals such as Shigeki Seto and Hitomi Yamada. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Haruaki Kurasaki is a distinguished inventor whose work in pharmaceutical research has led to valuable innovations. His patent for the 15-PGDH inhibitor exemplifies his dedication to improving healthcare solutions. His collaborations and career at Kyorin Pharmaceutical Co., Ltd. further underscore his impact in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…